DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,376,234 | +9.4% | 53,914 | +5.8% | 1.39% | +15.8% |
| Q2 2023 | $12,226,658 | +28.1% | 50,944 | +34.5% | 1.20% | +21.5% |
| Q1 2023 | $9,548,221 | +189.1% | 37,883 | +204.5% | 0.98% | +139.1% |
| Q4 2022 | $3,302,621 | +10.8% | 12,443 | +7.8% | 0.41% | -0.7% |
| Q3 2022 | $2,982,000 | +2.4% | 11,545 | +0.5% | 0.42% | +7.0% |
| Q2 2022 | $2,912,000 | -13.1% | 11,485 | +0.5% | 0.39% | +1.8% |
| Q1 2022 | $3,351,000 | -10.2% | 11,425 | +0.7% | 0.38% | -5.9% |
| Q4 2021 | $3,733,000 | +8.0% | 11,345 | -0.0% | 0.40% | +532.8% |
| Q3 2021 | $3,455,000 | +10.3% | 11,350 | -2.8% | 0.06% | -83.2% |
| Q2 2021 | $3,133,000 | +21.1% | 11,675 | +1.5% | 0.38% | +12.4% |
| Q1 2021 | $2,588,000 | +16.5% | 11,500 | +15.0% | 0.34% | +6.0% |
| Q4 2020 | $2,221,000 | -99.8% | 9,999 | +73.4% | 0.32% | +50.5% |
| Q3 2020 | $1,241,593,000 | +120326.1% | 5,766 | -1.1% | 0.21% | +8.7% |
| Q2 2020 | $1,031,000 | +70.1% | 5,831 | +33.1% | 0.20% | +38.3% |
| Q1 2020 | $606,000 | -99.9% | 4,381 | -8.4% | 0.14% | +11.0% |
| Q4 2019 | $734,095,000 | +121238.0% | 4,783 | +14.1% | 0.13% | +7.6% |
| Q3 2019 | $605,000 | +5.2% | 4,191 | +4.2% | 0.12% | +1.7% |
| Q2 2019 | $575,000 | +10.2% | 4,023 | +1.7% | 0.12% | +9.4% |
| Q1 2019 | $522,000 | +34.5% | 3,956 | +5.0% | 0.11% | +19.1% |
| Q4 2018 | $388,000 | +4.9% | 3,766 | 0.0% | 0.09% | +18.7% |
| Q3 2018 | $370,000 | -0.8% | 3,766 | -0.4% | 0.08% | +7.1% |
| Q2 2018 | $373,000 | -0.8% | 3,781 | -1.6% | 0.07% | -4.1% |
| Q1 2018 | $376,000 | +8.7% | 3,841 | +3.1% | 0.07% | +12.3% |
| Q4 2017 | $346,000 | +12.0% | 3,726 | +3.5% | 0.06% | +6.6% |
| Q3 2017 | $309,000 | +0.3% | 3,601 | -2.3% | 0.06% | +3.4% |
| Q2 2017 | $308,000 | -2.2% | 3,686 | 0.0% | 0.06% | -7.8% |
| Q1 2017 | $315,000 | +9.8% | 3,686 | 0.0% | 0.06% | +6.7% |
| Q4 2016 | $287,000 | -8.6% | 3,686 | -8.0% | 0.06% | -13.0% |
| Q3 2016 | $314,000 | -22.5% | 4,006 | 0.0% | 0.07% | -21.6% |
| Q2 2016 | $405,000 | +7.1% | 4,006 | +0.5% | 0.09% | +6.0% |
| Q1 2016 | $378,000 | +2.2% | 3,986 | 0.0% | 0.08% | -1.2% |
| Q4 2015 | $370,000 | -4.4% | 3,986 | -12.1% | 0.08% | -5.6% |
| Q3 2015 | $387,000 | +10.3% | 4,536 | +10.6% | 0.09% | +29.0% |
| Q2 2015 | $351,000 | +9.7% | 4,103 | +8.8% | 0.07% | +11.3% |
| Q1 2015 | $320,000 | +15.9% | 3,770 | +17.1% | 0.06% | +10.7% |
| Q4 2014 | $276,000 | +26.6% | 3,220 | +12.2% | 0.06% | +16.7% |
| Q3 2014 | $218,000 | 0.0% | 2,870 | +3.6% | 0.05% | +2.1% |
| Q2 2014 | $218,000 | +4.8% | 2,770 | 0.0% | 0.05% | -4.1% |
| Q1 2014 | $208,000 | +0.5% | 2,770 | +3.2% | 0.05% | -5.8% |
| Q4 2013 | $207,000 | – | 2,685 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |